You just read:

Regen BioPharma, Inc. Presents Preclinical Proof-of-Concept of DiffronC Effectiveness at the International Society for Stem Cell Research (ISSCR) Annual Meeting

News provided by

Regen BioPharma, Inc.

Jul 14, 2015, 08:30 ET